Tri­fec­ta of in­com­ing mi­graine meds must be cheap­er than trip­tans to be cost-ef­fec­tive — ICER

For mi­graine suf­fer­ers who ben­e­fit from trip­tans — ig­nore the new crop of in­com­ing acute mi­graine med­ica­tions — be­cause your ex­ist­ing gener­ic med­i­cines are more ef­fec­tive and …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER